COPD infective exacerbation — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Refer for assessment for COPD exacerbation treatment
This scenario assesses COPD infective exacerbation in a UK pharmacy practice context. Purulent sputum with increased breathlessness and volume suggests an exacerbation that may need prescribed treatment. The best answer is Refer for assessment for COPD exacerbation treatment because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.
Reference: NICE CKS; BNF